Beckman Coulter Diagnostics expands Alzheimer’s disease portfolio with CE-marked p-Tau217 blood test and brain-derived research assay
Assay enables laboratories across Europe and other CE-recognizing markets to scale blood-based Alzheimer’s disease testing and advance research into amyloid and tau pathology























